Zim Laboratories Ltd

NSE: ZIMLAB · BSE: 541400 · Pharmaceuticals & Biotechnology · 39 announcements

Share price: ₹134.66
Market cap: ₹722.6 Cr
Revenue (annual): ₹374.4 Cr
Net profit (annual): ₹5.84 Cr
P/E (TTM): 348.8×Sector 43.8×
Promoter holding: 30.30%-0.06% QoQ
FII holding: 0.17%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Employee Stock Options 6 Merger & Restructuring 5 Earnings Call 5 Annual General Meeting 5 Financial Results 4 Board Meeting Date 3 Regulatory Approval 2 Promoter Buying (Off-Market) 2 Other Announcement 2 Management Change 1 Credit Rating 1 Business Update 1 Annual Report 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

16 Sep 2026 13:00 IST NSE

Acquisition

Zim Laboratories Acquisition Worth ₹1.56 Cr

ZIM WOS completed a ₹1.56 Crore investment in stepdown ZIM Scientific Office L.L.C., Dubai, fulfilling the board-approved capital plan. The transaction closes the acquisition announced in August 2025.

Value: ₹1.56 Cr

Open announcement → Read the filing ↗